News

Dec 2

MitoSense, Inc. Secures U.S. Patent for Innovative Treatment of Neurodegenerative Diseases

Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...

Nov 12

MitoSense Inc. Publishes Breakthrough Study on Cryopreserved Fibroblast and Mesenchymal Stem Cells as Alternative Mitochondrial Donors

Plymouth, MA – November 12, 2024 – MitoSense Inc., a leader in mitochondria lresearch and innovation, proudly announces the publication...

Sep 6

MitoSense Applauds Elliott Mitochondria Research Center's Benefit Concert: A Night to END ALS & TBI

September 6, 2024 – Tampa, FL – MitoSense, holder of an exclusive license on groundbreaking technology from the Elliott Mitochondria...

Aug 19

MitoSense to Attend MHSRS, August 26th -29th

MitoSense, Inc. is proud to announce its participation in the 2024 Military Health System Research Symposium (MHSRS), taking place August...